Skip to main content

brolucizumab

Generic: brolucizumab·Brand: Beovu

brolucizumab: 2 clinical trials tracked.

brolucizumab evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about brolucizumab, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Diabetic Macular Edema (DME)

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

A Prospective, Multi-center, Open-label, Phase IV Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Diabetic Macular Edema (DME).

NCT05959304Registry updated 2026-04-13·Phase 4
Completed

Primary endpoint: Incidence and characteristics of treatment-emergent adverse events during the 40 weeks of treatment with Brolucizumab.

Interventionalopen66 enrolledStarted 2024-12Completion 2025-118 sites · IndiaNovartis Pharmaceuticals

OBservationaL stUdy to Evaluate Fluid reSolution and Effectiveness in Patients Receiving Beovu (Brolucizumab) Under KeY Treatment Schemes in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

NCT04543331Registry updated 2026-07-29
Completed

Primary endpoint: Percentage of patients' eyes that are absent of subretinal fluid (SRF) and intra-retinal fluid (IRF)

Observational572 enrolledStarted 2020-11Completion 2025-1141 sites · GermanyNovartis Pharmaceuticals